IL-17 in Chronic Obstructive Pulmonary Disease
Author Information
Author(s): Chang Ying, Nadigel Jessica, Boulais Nicholas, Bourbeau Jean, Maltais François, Eidelman David H, Hamid Qutayba
Primary Institution: McGill University
Hypothesis
The study investigates the role of IL-17A and IL-17F in the pathogenesis of chronic obstructive pulmonary disease (COPD).
Conclusion
The study found that IL-17A and IL-17F are expressed at higher levels in the airways of COPD patients compared to controls, suggesting their involvement in the disease's pathogenesis.
Supporting Evidence
- IL-17F immunoreactivity was significantly higher in the bronchial biopsies of COPD patients compared to control subjects.
- The absolute number of both IL-17A and IL-17F positive cells was higher in COPD patients.
- The expression of IL-17A and IL-17F was co-localized with CD4 and CD8 T cells.
Takeaway
This study shows that certain immune cells in the lungs of people with COPD make more of a protein called IL-17, which might help explain why their lungs are inflamed.
Methodology
The study used bronchoscopic biopsies from COPD patients and control subjects to analyze IL-17A and IL-17F expression through immunohistochemistry and RT-PCR.
Limitations
The study did not include smokers without COPD as a control group, which may limit the comparison.
Participant Demographics
{"COPD":{"number":16,"age":"53 ± 6","male_female_ratio":"10/6","current_ex_smokers":"7/8"},"controls":{"number":15,"age":"48 ± 9","male_female_ratio":"11/4","current_ex_smokers":"0/3"}}
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website